Marvell's setup played out with a 7% move, and the shares remain worth holding. Gamma positioning shows $240-$250 will be a grind, so near-term upside may stall there. x.comÂ
The Traveling Trader
Founder of The Traveling Trader, Market-Open Livestreams
Marvell can easily reach $250 this year after beating and raising guidance. Per @Noamneo_, it posted record Q1 revenue of $2.42B and crushed EPS estimates, and data center is now 76% of the business and still exploding. x.com x.comÂ
Marvell looks set for new all-time highs as heavy call buying signals someone making a massive bet. More than $1.5 million of monthly calls came through in a single day, and the technicals look great. @AdityaInvests90 notes it bounced off its 50 EMA, which last time preceded a 100% move, putting previous highs near $330 in view. x.com x.comÂ
Marvell's jump to $290 on its S&P 500 inclusion is a forced institutional pump that looks like a short-term top. Once index funds finish their mechanical rebalancing, that artificial demand dries up and often triggers a sharp sell-the-news flush. The large gap below on the chart acts as a magnet, pointing to a healthy pullback toward the $214-220 zone, where $214 lines up with the 0.786 Fibonacci level. x.comÂ
A Lumentum deal would put Marvell in a much better competitive position, making its shares an obvious buy here, especially for existing Lumentum shareholders. If the deal breaks, Marvell shares would jump sharply; a moderate premium could mean near-term weakness or sideways trading but would be a great long-term deal. A big premium could push shares down further, though much of that risk is already priced in. x.com x.comÂ
Long-dated call buying and $150 put selling suggest institutions are positioned for upside in Nebius into 2027, a stronger bullish read than Marvell. Unusual Whales data show over $25 million in two call blocks, though one may be a roll, and over $12 million in $150 puts sold. The 19% two-day bounce lacked confirming options inflows, so Nebius could retest $170 before Nov. 10 earnings, with a roughly 18% implied move. x.comÂ
Marvell's risk/reward is no longer favorable after the stock ran three to four times from the $70s in March, when it was the most obviously undervalued chip stock. Jensen Huang's call for a $1T company is partly driven by his dislike of Broadcom's Hock Tan, and the Celestial AI angle is overhyped relative to the value it adds. A bounce is likely from here, but there is no case for adding exposure at the current price. x.com x.com x.comÂ
Marvell's $70-90 billion FY31 revenue target looks credible: COO Chris Koopmans said key foundry, substrate and packaging suppliers get five-year forecasts and had already seen it before investor day. A $500 price target still looks too aggressive for now; Marvell must show it can grow its networking and photonics segment to deserve a safe price increase. x.com x.comÂ
Marvell trades at one of the lowest PEG ratios in chips with one of the highest composite ratings, and its cup-and-handle breakout points to a 330 price target. x.comÂ
Marvell's run looks like distribution, not accumulation: it doubled in four months on decelerating earnings, spiked on a CEO's compliment and printed its heaviest volume at the top. After Jensen Huang called it the next trillion-dollar company at Computex, it jumped 32% in a day, capping a 105% gain in 18 weeks on record volume of 441 million shares, while EPS growth slowed four straight quarters from 158% to 29%. A 40% collapse from the peak in five weeks followed, the mark of a climax run. … Show more
Marvell looks interesting at less than 30x calendar-2027 EPS against expected 60-70% annual EPS growth, but overpaying for Lumentum could drive its shares lower. Marvell could pay up to $110B, roughly a 30% premium; the stock-versus-debt mix is unclear, and Lumentum holders might own a third of the combined company. If the deal falls apart, Marvell could rise 10-12%. x.comÂ